CClinicalTrials.gg
Status unknownNCT05632692Updated Nov 30, 2022

Menthol Mouth Rinsing and Performance Responses of Elite Football Referees in the Heat

An interventional study of Menthol solution in Exercise Induced Hyperthermia and Performance Demands of Exercising in the Heat, sponsored by Universidade do Porto. Status unknown. Open to male participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-11-30.

Sponsored by Universidade do Porto · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

Ten male football referees will be recruited to perform two intermittent football protocols , separated by at least 7 days (wash-out period). After passing the eligibility criteria, the participants will be randomly assigned, according to a computer-generated allocation schedule, to 1 of 2 beverages sequences: (1) intervention - menthol solution 0.01% (room temperature) and (2) placebo - noncaloric berry-flavoured solution (room temperature). The participants will be provided with one of the 2 beverages before warm-up (pre-cooling) and at the half-time (per-cooling). The trials will follow a randomised counterbalanced crossover design, blinded to the participants, and will take place in indoor facilities, where WBGT exceed 30◦C, at the same time of the day, to control for circadian variations. Each trial involves an exercise protocol (SAFT-90), lasting 90 minutes, separated into two 45-minute parts. The first half will be preceded by a warm-up and the second half by a 15-minute break.

The results of this study are expected to determine whether mouth rinsing a menthol solution, before a football exercise protocol performed in the heat, will help to alleviate physiological strain and improve performance parameters, comparing to a non-cooling strategy, in elite male football referees. Thus, we can be closer to defining nutritional strategies of internal cooling, that will be an advantage for the performance of the football referees, concretely in the competitions carried out under adverse environmental conditions.

02

Conditions studied

  • Exercise Induced Hyperthermia
  • Performance Demands of Exercising in the Heat

Browse trials for

03

In context

Hyperthermia

478 studies on the registry are indexed under Hyperthermia; 92 are open to participants now.

This study's planned enrollment of 10 is below the median of 60 across 365 interventional studies indexed under Hyperthermia.

Browse Hyperthermia studies →

Lead sponsor

Universidade do Porto is the lead sponsor of 170 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Male football referees aged over 18 and under 45 years;
  2. With normal weight (BMI ≥ 18.5 and ≤ 24.9 kg/m2);
  3. Availability to participate in the introductory meeting, familiarization session and 2 experimental sessions;
  4. Ability to read and sign the informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Under the influence of any medications that may affect urinary parameters, thermoregulation mechanisms, circulatory system, thyroid and pituitary function or metabolic status;
  2. Injury, diabetes, autoimmune disease, cardiovascular disease or obstructive disease of the gastrointestinal tract (e.g., diverticulitis, inflammatory bowel disease);
  3. Schizophrenia, bipolar disorder or other psychotic disorders;
  4. Eating disorders;
  5. MRI scans scheduled within 48 hours after familiarization session or any of the experimental trials.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Intervention

    A menthol solution is going to be formulated by crushing and dissolving one noncalorific menthol candy drop (15 mg) in 150 ml of warm water, in order to obtain a solution with a concentration of 0.01%. Prior to use, solutions are going to be aliquoted for mouth rinse and warmed at room temperature. Then, it will be served to each participant on individual bottles in a total dose of 75 ml before exercise and 75 ml during exercise.

    Other: Menthol solution

  • Placebo comparator
    Placebo

    A placebo beverage is going to be prepared using noncaloric berry-flavored sweetener consisting of sucralose candy drops, which will be crushed and dissolved in 150 ml of warm water. Prior to use, solutions are going to be aliquoted for mouth rinse and warmed at room temperature. Then, it will be served to each athlete on individual bottles in a total dose of 75 ml before exercise and 75 ml during exercise.

    Other: Menthol solution

Interventions

  • OtherMenthol solution

    Menthol application, through oral solutions, stimulates the mandibular and maxillary branches of the trigeminal nerve (which are predominantly responsible for detection of temperature and nociceptive stimuli across the face and within the oral cavity) and has consistently shown to improve thermal comfort and decrease thermal sensation, which are thought to modulate perceived exertion to improve performance in the heat.

06

What researchers measure

Primary outcomes

  1. Heart rate change

    Heart rate is a physiological parameter of performance and will be measured through HR monitors (Polar H10 Heart Rate Sensor, USA). PolarH10 can accurately measure mean HR and low-frequency oscillations (up to 0.15 Hz) of HR at rest and during exercise.

    Time frame: A change in heart rate from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed.

  2. Sweating rate at the first half

    Sweating rate is a physiological parameter of performance and is going to be calculated recurring to the following equation : SR= (Pre exercise body weight - postexercise body weight + fluid intake - urine volume)/(exercise time in hours).

    Time frame: Sweating rate is going to be calculated at the end of the first half of the exercise protocol (after 45 min of exercise)

  3. Sweating rate at the second half

    Sweating rate is a physiological parameter of performance and is going to be calculated recurring to the following equation : SR= (Pre exercise body weight - postexercise body weight + fluid intake - urine volume)/(exercise time in hours).

    Time frame: Sweating rate is going to be calculated at the end of the second half of the exercise protocol (after 90 min of exercise)

  4. Core temperature change

    Core temperature is a physiological parameter of performance and can be accessed using a telemetric pill ingested 30 minutes prior the start of the exercise (BodyCap®, France). Due to the good measuring accuracy, the ability to measure in field-based situations and the non-invasive character of this temperature measurement method, the ingestible telemetric temperature pill is suitable to assess core temperature during exercise

    Time frame: A change in core temperature from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed

  5. Ratings of perceived exertion (RPE)

    RPE is a subjective psychological/perceptual parameter that impacts performance and will be recorded through CR-10 Borg scale that goes from 0 ("rest") to 10 ("maximal effort").

    Time frame: RPE is going to be accessed at the end of the exercise protocol.

  6. Thermal comfort (TC) change

    TC is a subjective psychological/perceptual parameter that influences performance and is going to be accessed according to a 6-point scale from to -3 ("very uncomfortable) to 3 ("very comfortable").

    Time frame: A change in TC from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.

  7. Thermal sensation (TS) change

    TS is a subjective psychological/perceptual parameter that impacts performance and will be recorded with a 9-point scale from -4 ("very cold") to 4 ("very warm").

    Time frame: A change in TS from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.

  8. Perceived thirst (PT) change

    PT is a subjective marker of hydration status and will be evaluated recurring to a 7-point scale from 1 ("not thirsty at all") to 7 ("very, very thirsty")

    Time frame: A change in PT from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.

  9. Physical performance change

    Physical performance responses will be measured using 100 Hz accelerometery, with Sonda 4.0 software (StatSports®, UK) to estimate total distance, sprint distance, accelerations and decelerations number

    Time frame: A change in each physical performance indicator from baseline (immediately after the warm-up) to each 15-minute block of the exercise protocol will be assessed

Secondary outcomes

  1. Hydration status before

    Hydration status is going to be assessed recurring to urine test strip (Combur10 Test M, Roche) and Urisys 1100® analyser (Roche, Switzerland).

    Time frame: Hydration status is going to be recorder at baseline (pre-exercise)

  2. Hydration status after

    Hydration status is going to be assessed recurring to urine test strip (Combur10 Test M, Roche) and Urisys 1100® analyser (Roche, Switzerland).

    Time frame: Hydration status is going to be recorder at the end of the exercise protocol

  3. Ad libitum fluid intake at the first half

    Fluid intake is going to be recorded via the measurement of mass change of the individual bottles provided to the referees at the warm-up and at the end of the session, to the nearest 0.1 ml (Seca, Hamburg, Germany).

    Time frame: Ad libitum fluid intake is going to be assessed at the end of the first half of the exercise protocol (after 45 min of exercise)

  4. Ad libitum fluid intake at the second half

    Fluid intake is going to be recorded via the measurement of mass change of the individual bottles provided to the referees at the warm-up and at the end of the session, to the nearest 0.1 ml (Seca, Hamburg, Germany).

    Time frame: Ad libitum fluid intake is going to be assessed at the end of the second half of the exercise protocol (after 90 min of exercise)

  5. Blood lactate levels before

    Blood lactate levels will be measured recurring to a Blood Lactate Meter (Lactate Pro 2, Arkray, U.S.A).

    Time frame: Blood lactate levels are going to be recorded before the start of the exercise protocol

  6. Blood glucose levels before

    Blood glucose levels will be measured recurring to a Glucometer (FreeStyle Precision Neo, Abbott Laboratories, U.S.A).

    Time frame: Blood glucose levels are going to be recorded before the start of the exercise protocol

  7. Blood glucose levels after

    Blood glucose levels will be measured recurring to a Glucometer (FreeStyle Precision Neo, Abbott Laboratories, U.S.A).

    Time frame: Blood glucose levels are going to be recorded immediately after the end of the exercise protocol

  8. Blood lactate levels after

    Blood lactate levels will be measured recurring to a Blood Lactate Meter (Lactate Pro 2, Arkray, U.S.A).

    Time frame: Blood lactate levels are going to be recorded immediately after the end of the exercise protocol

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05632692
Lead sponsor
Universidade do Porto
Responsible party
Sponsor
First posted
Nov 30, 2022
Start date
Apr 10, 2023 (estimated)
Primary completion
May 1, 2023 (estimated)
Completion
Jun 1, 2023 (estimated)
Last update
Nov 30, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion